Severe hypofractionation: Non-homogeneous tumour dose delivery can counteract tumour hypoxia

Acta Oncologica

Volumn 49, Issue 8, 2010, Pages 1304-1314

  Ruggieri, Ruggero ^a   Naccarato, Stefania ^a   Nahum, Alan E ^b  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; ESOPHAGUS; HEART; HUMAN; HUMAN TISSUE; HYPOXIA; LUNG; LUNG NON SMALL CELL CANCER; OXYGEN ENHANCEMENT RATIO; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; REOXYGENATION; SPINAL CORD; STEREOTACTIC BODY RADIATION THERAPY; TUMOR VOLUME;

EID: 77958168846     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.486796     Document Type: Article

References (33)

1. Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-55.
2. Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 2001;51:666-70.
3. Fowler JF, Tomé WA, Fenwick JD, Metha MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004;60:1241-56.
4. Kwa S L S, Lebesque JV, Theuws J C M, Marks LB, Munley MT, Bentel G, et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998;42:1-9.
5. Robertson JM, Ten Haken RK, Hazuka MB, Turrisi AT, Martel MK, Pu AT, et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1079-85.
6. Gagliardi G, Bjöhle J, Lax I, Ottolenghi A, Eriksson F, Liedberg A, et al. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 2000;46:373-81.
7. Wulf J, Baier K, Mueller G, Flentje MP. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005;77:83-7.
8. Ruggieri R, Nahum AE. The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumour subvolumes. Med Phys 2006;33:4044-55.
9. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 1989;16:1623-30.
10. Lyman JT. Complication probability as assessed from dosevolume histograms. Radiat Res 1985;8: S13-S19.
11. Ruggieri R. Hypofractionation in non-small cell lung cancer (NSCLC): Suggestions from modelling both acute and chronic hypoxia. Phys Med Biol 2004;49:4811-23.
12. Carlson DJ, Stewart RD, Semenenko VA. Effects of oxygen on intrinsic radiation sensitivity - a test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. Med Phys 2006;33:3105-15.
13. Popple RA, Ove R, Shen S. Tumour control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. Int J Radiat Oncol Biol Phys 2002;54:921-7.
14. Schultheiss TE, Orton CG. Models in radiotherapy: Definition of decision criteria. Med Phys 1985;12:183-7.
15. Seppenwolde Y, Lebesque JV, De Jaeger K, Belderbos J S A, Boersma LJ, Schilstra C, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2003;55:724-35.
16. Polico R, Stea L, Antonello M, Princivalli M, Marchetti C, Busetto M, et al. The polycentric multiple arc complanar technique, or telebrachyterapy. A 4-year experience (an innovative way for the local control of solid neoplasms). Radiol Med 1995;90:113-23.
17. Martel MK, Ten Haken RK, Hazuka MB, Kessler ML, Strawderman M, Turrisi AT, et al. Estimation of tumour control probability model parameters from 3-D dose distribution of non-small cell lung cancer patients. Lung Cancer 1999;24:31-7.
18. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
19. Werner-Wasik M, Pequignot E, Leeper D, Hauck W, Curran W. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: A multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys 2000;48:689-96.
20. Burman C, Kutcher GJ, Emami B, Goiten M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123-35.
21. Metha M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001;49:23-33.
22. rd ed. London: Arnold; 2002. pp. 147-57.
23. Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 1993;38:653-66.
24. Nahum AE, Movsas B, Horwitz EM, Stobbe CC, Chapman JD. Incorporating clinical measurements of hypoxia into tumour local control modeling of prostate cancer: Implications for the α/β ratio. Int J Radiat Oncol Biol Phys 2003;57:391-401.
25. Zölzer F, Streffer C. Increased radiosensitivity with chronic hypoxia in four human tumour cell lines. Int J Radiat Oncol Biol Phys 2002;54:910-20.
26. Ljungkvist A S E, Bussink J, Kaanders J H A M, Rijken P F J W, Begg AC, Raleigh JA, et al. Hypoxic cell turnover in different solid tumor lines. Int J Radiat Oncol Biol Phys 2005;62:1157-68.
27. Williams KJ, Telfer BA, Xenaki D, Sheridan MR, Desbaillets I, Peters H J W, et al. Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1. Radiother Oncol 2005;75:89-98.
28. Sundfør K, Lyng H, Tropé CG, Rofstad EK. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pre-treatment tumor oxygenation and vascularization. Radiother Oncol 2000;54:101-7.
29. Van Putten LM, Kallman RF. Oxygenation status of a transplantable tumour during fractionated radiation therapy. J Natl Cancer Inst 1968;40:441-51.
30. Zywietz F, Reeker W, Kochs E. Tumour oxygenation in a transplanted rat rhabdomyosarcoma during fractionated irradiation. Int J Radiat Oncol Biol Phys 1995;32:1391-400.
31. Stadler P, Feldmann HJ, Creighton C, Kau R, Molls M. Changes in tumour oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer. Radiother Oncol 1998;48:157-64.
32. Baumann M, Appold S, Zimmer J, Scharf M, Beuthien-Baumann B, Dubben H, et al. Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy. Acta Oncol 2001;40:519-28.
33. Speke A, Hill RP. The effects of clumping and reoxygenation on repopulation during fractionated irradiation. Int J Radiat Oncol Biol Phys 1995;31:857-63.